Adenovirus CCL-21 transduced MART-1/gp100/tyrosinase/NY-ESO-1 peptide-pulsed dendritic cells

· H. Lee Moffitt Cancer Center and Research Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adenovirus CCL-21 transduced MART-1/gp100/tyrosinase/NY-ESO-1 peptide-pulsed dendritic cells, covering 2012-09-24 to 2012-09-24. Get the full timeline:

Most recent: Clinical Trial Update: Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured [Phase 1]

See pricing